Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: A Delphi consensus statement

Expert Opinion on Drug Delivery

Volumn 11, Issue 3, 2014, Pages 313-323

  Ninane, Vincent ^a   Brusselle, Guy G ^b   Louis, Renaud ^c   Dupont, Lieven ^d   Liistro, Giuseppe ^e   De Backer, Wilfried ^f   Schlesser, Marc ^g   Vincken, Walter ^h  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^g CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^h UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Consensus; Delphi survey; Inhalation device; Questionnaire

Indexed keywords

ASTHMA; CONSENSUS; DRUG SUBSTITUTION; ECONOMICS; FEE; HUMAN; NEBULIZER; PATIENT EDUCATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; UTILIZATION;

ASTHMA; CONSENSUS; DRUG SUBSTITUTION; HUMANS; NEBULIZERS AND VAPORIZERS; PATIENT EDUCATION AS TOPIC; PRESCRIPTION FEES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES;

EID: 84894463551     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2014.872626     Document Type: Article

References (29)

1. Global Initiative for Asthma. Global strategy for asthma management and prevention (updated 2012). 2012. Available from: Http://www. ginasthma.org
2. Broeders ME, Vincken W, Corbetta L. The ADMIT series-issues in inhalation therapy. 7. Ways to improve pharmacological management of COPD: The importance of inhaler choice and inhalation technique. Prim Care Respir J 2011;20:338-43
3. Cochrane MG, Bala MV, Downs KE, et al. Inhaled corticosteroids for asthma therapy: Patient compliance, devices, and inhalation technique. Chest 2000;117:542-50
4. Laube BL, Janssens HM, de Jongh FH, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011;37:1308-31
5. Michele TM, Pinheiro S, Iyasu S. The safety of tiotropium-The FDA's conclusions. N Engl J Med 2010;363:1097-9
6. Accordini S, Corsico AG, Braggion M, et al. The cost of persistent asthma in Europe: An international populationbased study in adults. Int Arch Allergy Immunol 2013;160: 93-101
7. Nowak D, Berger K, Lippert B, et al. Epidemiology and health economics of COPD across Europe: A critical analysis. Treat Respir Med 2005;4:381-95
8. Agence Federale des Medicaments et des Produits de Sante. Regles operationnelles pour la prescription en DCI dans la pratique medicale et pharmaceutique et dans le dossier medical electronique. 2011. Available from: http://www.faggafmpsbe
9. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31: 143-78
10. Dekhuijzen P, Picado C, Lavorini F, et al. Inhaler choice in asthma and COPD: A poorly addressed issue in guidelines. 6th IPCRG World Conference; Edinburgh; 2012. Available from: Https://www. theipcrg.org/display/ EVENTSEdinburgh
11. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55
12. Hsu CC, Sandford B. The Delphi technique: Making sense of consensus. PARE 2007;12:1-8
13. Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: An American College of Chest Physicians Delphi consensus statement. Chest 2001;119:590-602
14. Delbecq AL, Van de Ven AH, Gustafson DH. Group techniques for program planning: A guide to nominal group and Delphi processes. Scott Foresman Co; Glenview, IL: 1975
15. Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: Recommendations for the future based on a systematic review of existing studies. PLoS Med 2011;8:e1000393
16. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2013). 2013. Available from: Http://www. Goldcopdorg
17. Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127:335-71
18. Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs 2000;32(4):1008-15
19. Plaza V, Calle M, Molina J, et al. External validation of the recommendations of the multidisciplinary consensus about inhaled therapies. Arch Bronconeumol 2012;48: 189-96
20. Song WS, Mullon J, Regan NA, Roth BJ. Instruction of hospitalized patients by respiratory therapists on metered-dose inhaler use leads to decrease in patient errors. Respir Care 2005;50:1040-5
21. Vincken W, Dekhuijzen PR, Barnes P. The ADMIT series - issues in inhalation therapy. 4) how to choose inhaler devices for the treatment of COPD. Prim Care Respir J 2010;19:10-20
22. Mehuys E, Van BL, De BL, et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J 2008;31:790-9
23. Kucukarslan S, Lai S, Dong Y, et al. Physician beliefs and attitudes toward collaboration with community pharmacists. Res Social Adm Pharm 2011;7:224-32
24. Williams AE, Chrystyn H. Survey of pharmacists' attitudes towards interchangeable use of dry powder inhalers. Pharm World Sci 2007;29:221-7
25. Takemura M, Mitsui K, Ido M, et al. Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients. Int J Chron Obstruct Pulmon Dis 2013;8:239-44
26. Thomas M, Price D, Chrystyn H, et al. Inhaled corticosteroids for asthma: Impact of practice level device switching on asthma control. BMC Pulm Med 2009;9:1
27. Price D. Do healthcare professionals think that dry powder inhalers can be used interchangeably?. Int J Clin Pract Suppl 2005;149:26-9
28. Price D, Summers M, Zanen P. Could interchangeable use of dry powder inhalers affect patients?. Int J Clin Pract Suppl 2005;149:3-6
29. Vinchurkar S, De Backer L, Vos W, et al. A case series on lung deposition analysis of inhaled medication using functional imaging based computational fluid dynamics in asthmatic patients: Effect of upper airway morphology and comparison with in vivo data. Inhal Toxicol 2012;24:81-8